2004
DOI: 10.1124/jpet.103.063511
|View full text |Cite
|
Sign up to set email alerts
|

ReN-1869 [(R)-1-(3-(10,11-Dihydro-5 H-dibenzo[a,d]cyclohepten-5-ylidene)-1-propyl)-3-piperidine Carboxylic Acid], a Novel Histamine H1 Receptor Antagonist, Produces Potent and Selective Antinociceptive Effects on Dorsal Horn Neurons after Inflammation and Neuropathy

Abstract: We characterized the effect of a novel selective histamine H1 receptor antagonist, (R)-1-(3-(10,11-dihydro-5H-dibenzo [a,d] cyclohepten-5-ylidene)-1-propyl)-3-piperidine carboxylic acid (ReN-1869), on the responses of dorsal horn neurons in anesthetized rats after carrageenan induced-inflammation and peripheral neuropathy (L5/6 spinal nerve ligation; SNL). ReN-1869 was administered systemically (0.1-4 mg/kg), and drug effects were assessed using a wide range of peripheral electrical and natural stimuli (brus… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2006
2006
2011
2011

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 37 publications
0
1
0
Order By: Relevance
“…One hour stimulation of mast cells with TNP is sufficient to induce degranulation, release of histamine and other preformed mediators [26]. Intrathecal histamine administration is pro-nociceptive in mice [27] and spinal histamine receptor antagonists show anti-nociceptive efficacy in various animal models [28]. Given the heterogeneity of mast cells between tissues responsible for their phenotype [1,29] and even within the dura [17], we believe that using mouse bone-marrow cultured mast cells which are less homogeneous than their rat equivalents [30] is still appropriate here.…”
Section: Discussionmentioning
confidence: 99%
“…One hour stimulation of mast cells with TNP is sufficient to induce degranulation, release of histamine and other preformed mediators [26]. Intrathecal histamine administration is pro-nociceptive in mice [27] and spinal histamine receptor antagonists show anti-nociceptive efficacy in various animal models [28]. Given the heterogeneity of mast cells between tissues responsible for their phenotype [1,29] and even within the dura [17], we believe that using mouse bone-marrow cultured mast cells which are less homogeneous than their rat equivalents [30] is still appropriate here.…”
Section: Discussionmentioning
confidence: 99%